These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 8371026)
1. BCG vaccination protects against leprosy in Venezuela: a case-control study. Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026 [TBL] [Abstract][Full Text] [Related]
2. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364 [TBL] [Abstract][Full Text] [Related]
3. [The protective efficacy of BCG against leprosy in São Paulo, Brazil]. Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil. Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274 [TBL] [Abstract][Full Text] [Related]
5. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya. Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of BCG against leprosy in São Paulo. Lombardi C; Pedrazzani ES; Pedrazzani JC; Filho PF; Zicker F Bull Pan Am Health Organ; 1996 Mar; 30(1):24-30. PubMed ID: 8919722 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India. Zodpey SP; Ambadekar NN; Thakur A Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132 [TBL] [Abstract][Full Text] [Related]
8. Long lasting BCG protection against leprosy. Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023 [TBL] [Abstract][Full Text] [Related]
9. Association between leprosy and HIV infection in Tanzania. van den Broek J; Chum HJ; Swai R; O'Brien RJ Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):203-10. PubMed ID: 9251592 [TBL] [Abstract][Full Text] [Related]
10. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon. Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973 [TBL] [Abstract][Full Text] [Related]
11. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma. Bechelli LM; Lwin K; Gallego Garbajosa P; Mg-Mg-Gyi ; Uemura K; Sundaresan T; Tamondong C; Matejka M; Sansarricq H; Walter J Bull World Health Organ; 1974; 51(1):93-9. PubMed ID: 4281729 [TBL] [Abstract][Full Text] [Related]
12. Effect of BCG on the risk of leprosy in an endemic area: a case control study. Muliyil J; Nelson KE; Diamond EL Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):229-36. PubMed ID: 2071979 [TBL] [Abstract][Full Text] [Related]
13. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae. Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275 [TBL] [Abstract][Full Text] [Related]
14. Immunoepidemiological studies on subclinical infection among leprosy household contacts in Thailand. Sampatavanich S; Sampoonachot P; Kongsuebchart K; Ramasoota T; Pinrat U; Mongkolwongroi P; Ozawa T; Sasaki N; Abe M Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):752-65. PubMed ID: 2681458 [TBL] [Abstract][Full Text] [Related]
15. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma. Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India. Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India. Rahete NP; Zodpey SP; Kamble KM Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467 [TBL] [Abstract][Full Text] [Related]
18. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bagshawe A; Scott GC; Russell DA; Wigley SC; Merianos A; Berry G Bull World Health Organ; 1989; 67(4):389-99. PubMed ID: 2680140 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950 [TBL] [Abstract][Full Text] [Related]
20. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification. Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]